Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques

By Aggarwal A.   Schneider D.J.   Terrien E.F.   Sobel B.E.   Dauerman H.L.  

The American Journal of Cardiology, Vol. 93, Iss. 1, 2004-01 ,pp. : 6-9

Elsevier

Access to resources Recommend Favorite

Circulating soluble CD40 ligand mediates the interaction between neutrophils and platelets in acute coronary syndrome

By Setianto Budi   Hartopo Anggoro   Gharini Putrika   Anggrahini Dyah   Irawan Bambang  

Heart and Vessels, Vol. 25, Iss. 4, 2010-07 ,pp. : 282-287

Springer Publishing Company

Access to resources Recommend Favorite

Soluble CD40 Ligand Levels in Patients with Hypertension

By Sonmez Alper   Dogru T.   Yilmaz M.   Ocal R.   Ozgurtas T.   Kilic S.   Eyileten T.   Tasci I.   Erbil K.   Kocar I.  

Clinical and Experimental Hypertension, Vol. 27, Iss. 8, 2005-11 ,pp. : 629-634

Informa Healthcare

Access to resources Recommend Favorite

Soluble CD40 ligand is elevated in Type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function

By Lajer Maria   Tarnow Inge   Michelson Alan D.   Jorsal Anders   Frelinger Andrew L.   Parving Hans-Henrik   Rossing Peter   Tarnow Lise  

Platelets, Vol. 21, Iss. 7, 2010-11 ,pp. : 525-532

Informa Healthcare

Access to resources Recommend Favorite

Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation

By Yngen M.   Östenson C.-G.   Hu H.   Li N.   Hjemdahl P.   Wallén N.  

Diabetologia, Vol. 47, Iss. 3, 2004-03 ,pp. : 537-540

Springer Publishing Company

Access to resources Recommend Favorite